Detalhe da pesquisa
1.
Monitoring predominantly cytostatic treatment response with 18F-FDG PET.
J Nucl Med
; 50 Suppl 1: 97S-105S, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403880
2.
Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients.
J Nucl Med
; 49(6): 879-86, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483090
3.
Male breast cancer: is the scenario changing.
World J Surg Oncol
; 6: 58, 2008 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-18558006
4.
TIGR matrix for implant-based breast reconstruction - a long-term resorbable mesh.
Expert Rev Med Devices
; 15(9): 689-691, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139282
5.
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer.
Nucl Med Commun
; 35(1): 20-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24201549
6.
Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study.
Biomark Med
; 6(2): 231-3, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22448798
7.
Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data.
EJNMMI Res
; 2: 11, 2012 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22444834
8.
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.
Phys Med Biol
; 57(11): 3419-33, 2012 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572708
9.
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
Clin Cancer Res
; 17(24): 7673-83, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22038995
10.
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.
Clin Cancer Res
; 17(24): 7664-72, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22028493
11.
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹8F]fluorothymidine positron emission tomography.
Nucl Med Commun
; 32(11): 997-1004, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21862943
12.
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab.
Clin Cancer Res
; 16(16): 4236-45, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20682702
13.
Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.
Phys Med Biol
; 55(3): 695-709, 2010 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20071760
14.
Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography.
Clin Cancer Res
; 15(21): 6649-57, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19861447
15.
Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
Eur J Cancer
; 45(12): 2146-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19464163
16.
[11C]choline positron emission tomography in estrogen receptor-positive breast cancer.
Clin Cancer Res
; 15(17): 5503-10, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706823